Suppr超能文献

临床探究:哪些患有代谢综合征的患者能从二甲双胍治疗中获益?

Clinical Inquiry: Which patients with metabolic syndrome benefit from metformin?

作者信息

Stover Liz, Chi Jessica, Kelsberg Gary, Safranek Sarah

机构信息

Valley Family Medicine Residency, University of Washington at Renton, WA, USA.

University of Washington Health Sciences Library, Seattle, WA, USA.

出版信息

J Fam Pract. 2016 Nov;65(11):832-834.

Abstract

In patients with metabolic syndrome who are in the highest-risk quartile for progression to diabetes (predicted mean 3-year risk, 60%), metformin, 850 mg twice daily, reduces the absolute risk by about 20% over a 3-year period. Metformin doesn't reduce the incidence in patients at lower risk of progression.

摘要

在代谢综合征患者中,处于进展为糖尿病最高风险四分位数的患者(预测平均3年风险为60%),二甲双胍每日两次,每次850毫克,在3年期间可使绝对风险降低约20%。二甲双胍不会降低进展风险较低患者的发病率。

相似文献

2
The role of medicinal chemistry in treating obesity, diabetes and metabolic syndrome.
ChemMedChem. 2013 Apr;8(4):535-7. doi: 10.1002/cmdc.201300012.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验